BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1741214)

  • 1. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children.
    Allen DB; Goldberg BD
    Pediatrics; 1992 Mar; 89(3):416-21. PubMed ID: 1741214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study.
    Allen DB; Julius JR; Breen TJ; Attie KM
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2824-9. PubMed ID: 9709954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.
    Kubo T; Tanaka H; Inoue M; Kanzaki S; Seino Y
    Bone; 1995 Oct; 17(4):397-401. PubMed ID: 8573414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
    Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear growth response to exogenous growth hormone in children with short stature.
    Schwartz ID; Hu CS; Shulman DI; Root AW; Bercu BB
    Am J Dis Child; 1990 Oct; 144(10):1092-7. PubMed ID: 2403090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
    Crofton PM; Stirling HF; Schönau E; Kelnar CJ
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC; Kwan EY; Lim YJ; Lee AC; Tam CF; Lam KS
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
    Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
    Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R; Gunczler P; Esaa S; Weisinger JR
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term growth hormone therapy in short children without growth hormone deficiency.
    Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K
    Acta Paediatr Scand Suppl; 1990; 366():14-22; discussion 23. PubMed ID: 2206003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone.
    Bhasin S; He EJ; Kawakubo M; Schroeder ET; Yarasheski K; Opiteck GJ; Reicin A; Chen F; Lam R; Tsou JA; Castaneda-Sceppa C; Binder EF; Azen SP; Sattler FR
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4224-33. PubMed ID: 19837911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.
    Trivedi P; Hindmarsh P; Risteli J; Risteli L; Mowat AP; Brook CG
    J Pediatr; 1989 Feb; 114(2):225-30. PubMed ID: 2915282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth parameters, growth hormone (GH) response to clonidine and circulating insulin-like growth factor-I (IGF-I), free thyroxine (FT4) and cortisol concentrations in relation to glycaemic control in children with insulin-dependent diabetes mellitus.
    Soliman AT; Ahmed HI; Asfour MG
    J Trop Pediatr; 1996 Aug; 42(4):228-32. PubMed ID: 8816035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.
    Kirk JM; Trainer PJ; Majrowski WH; Murphy J; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):487-93. PubMed ID: 7955460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.